These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4833652)

  • 21. [Spectrophotometric determination of single components of binary mixtures. I. Phenylbutazone and phenamidofuryl].
    Guadagnini G; Perego R
    Boll Chim Farm; 1965 Dec; 104(12):815-8. PubMed ID: 5882891
    [No Abstract]   [Full Text] [Related]  

  • 22. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
    Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
    J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pressure-course events in the tabletting of phenylbutazone].
    Wenzel U; Kala H
    Pharmazie; 1984 Oct; 39(10):693-4. PubMed ID: 6522447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mechanism of action of 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine; complex forming ability of this compound and effects on diphosphopyridine nucleotide-dependent zinc enzymes].
    WALLENFELS K; SUND H
    Arzneimittelforschung; 1959 Feb; 9(2):81-9. PubMed ID: 13638188
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine (butazolidine) on cortisone metabolism in rat liver].
    DIRSCHERL W; KORUS W; SCHRIEFERS H
    Arzneimittelforschung; 1956 Oct; 6(10):596-8. PubMed ID: 13373678
    [No Abstract]   [Full Text] [Related]  

  • 26. Phenylbutazone peroxidatic metabolism and conjugation.
    Lakshmi VM; Zenser TV; Mattammal MB; Davis BB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):81-8. PubMed ID: 8331577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ON A NEW SALT WITH ANTI-INFLAMMATORY ACTIVITY].
    CERRI O; GUZZON V
    Boll Chim Farm; 1964 Apr; 103():245-54. PubMed ID: 14180462
    [No Abstract]   [Full Text] [Related]  

  • 28. [EXPERIMENTAL INFLAMMATION INDUCED BY A HEPARIN ANALOG. A TEST OF ANTI-INFLAMMATORY ACTIVITY].
    BRANCENI D; AZADIAN-BOULANGER G; JEQUIER R
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():15-24. PubMed ID: 14248342
    [No Abstract]   [Full Text] [Related]  

  • 29. [NOTE ON THE VALUE OF RESISTIVITY OF CG 21, A NEW SALT OF P-HYDROXPHENYLBUTAZONE].
    MARINI M
    Boll Chim Farm; 1964 Apr; 103():255-6. PubMed ID: 14180463
    [No Abstract]   [Full Text] [Related]  

  • 30. [Protein binding of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine and several other drugs].
    WUNDERLY C
    Arzneimittelforschung; 1956 Dec; 6(12):731-4. PubMed ID: 13395938
    [No Abstract]   [Full Text] [Related]  

  • 31. [Spectrophotometric analysis of phenylbutazone and aminopyrine in mixtures].
    Bagnarelli AE
    Rev Sanid Milit Argent; 1966; 65(1):92-8. PubMed ID: 5986739
    [No Abstract]   [Full Text] [Related]  

  • 32. [Photodegradation of 4-n-butyl-1,2-diphenylpyrazolidine-3,5-dione (phenylbutazone) (author's transl)].
    Reisch J; Weidmann KG; Triebe J
    Arch Pharm (Weinheim); 1977 Oct; 310(10):811-20. PubMed ID: 931566
    [No Abstract]   [Full Text] [Related]  

  • 33. Application of Henderson equation for the determination of weakly acidic pharmaceutical compounds. Part 3: Determination of phenylbutazone.
    El-Fatatry HM; Sharafel-Deen MM; Amer MM
    Pharmazie; 1979; 34(3):155-7. PubMed ID: 450955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine. I. Distribution in organism after a single intravenous injection].
    HEISE ER; KIMBEL KH
    Arzneimittelforschung; 1956 Dec; 6(12):722-4. PubMed ID: 13395933
    [No Abstract]   [Full Text] [Related]  

  • 35. [Sprectrophotometry of phenylbutazone].
    Magalhães JF; Piros MG
    Rev Farm Bioquim Univ Sao Paulo; 1973; 11(1):41-50. PubMed ID: 4789381
    [No Abstract]   [Full Text] [Related]  

  • 36. The biotransformation of phenylbutazone (Butazolidin).
    Faigle JW; Dieterle W
    J Int Med Res; 1977; 5 Suppl 2():2-14. PubMed ID: 410685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experiments on the effect of 3, 5-dioxo-1, 2-diphenyl-4-n-butyl-pyrazolidine in rats. II. Distribution of the drug in the organism after repeated oral doses].
    HEISE ER
    Arzneimittelforschung; 1956 Dec; 6(12):724-6. PubMed ID: 13395934
    [No Abstract]   [Full Text] [Related]  

  • 38. [Penetration of human aqueous humor by 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine (butazolidin)].
    MUNICH W
    Albrecht Von Graefes Arch Ophthalmol; 1958; 160(2):181-5. PubMed ID: 13545132
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of inhibitors on phenylbutazone oxidation--comparison of rapid tests of dosage forms].
    Kühn H
    Pharmazie; 1987 Feb; 42(2):127-8. PubMed ID: 3602051
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative structure-property relationship studies for direct photolysis rate constants and quantum yields of polybrominated diphenyl ethers in hexane and methanol.
    Fang L; Huang J; Yu G; Li X
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1587-93. PubMed ID: 18995905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.